JINYU: The gene-engineered subunit vaccine for bovine gas gangrene (Type A) has obtained a new veterinary drug registration certificate
I'm LongbridgeAI, I can summarize articles.According to the announcement from JINYU, the company has been approved by the Ministry of Agriculture and Rural Affairs of the People's Republic of China to develop a new veterinary drug, the genetically engineered subunit vaccine for Clostridium perfringens type A, in collaboration with other companies through its wholly-owned subsidiary Jinyu Baoling Biological Pharmaceutical Co., Ltd. (hereinafter referred to as "Jinyu Baoling"), in accordance with the national "Veterinary Drug Management Regulations" and "Veterinary Drug Registration Measures." The "New Veterinary Drug Registration Certificate" has been issued
According to the announcement from Zhitong Finance APP, JINYU (600201.SH) has released a notice stating that, in accordance with the national "Regulations on Veterinary Drugs" and "Measures for the Registration of Veterinary Drugs," the Ministry of Agriculture and Rural Affairs has reviewed and approved the new veterinary drug developed by the company's wholly-owned subsidiary Jinyu Baoling Biological Pharmaceutical Co., Ltd. (hereinafter referred to as "Jinyu Baoling") in collaboration with other companies, which is the genetically engineered subunit vaccine for Bovine Clostridium perfringens type A, and has issued the "New Veterinary Drug Registration Certificate."